Menu Back to 3rd-DIA-Labeling-Workshop-in-Japan

Program Committee

  • Akiyoshi  Uchiyama
    Akiyoshi Uchiyama President Artage Inc., Japan
  • Teiki  Iwaoka, PhD, MS
    Teiki Iwaoka, PhD, MS Executive Consultant & Global Auditor; Dir., Drug Safety Outsourcing Planning CAC ExiCare Corporation, Japan
  • Kana  Maruyama
    Kana Maruyama Labelling Department, Development and Medical Affairs Division GlaxoSmithKline K.K., Japan
  • Rie  Matsui, RPh
    Rie Matsui, RPh Director, Regional Labeling Head for Asia International Labeling Group Pfizer Japan Inc., Japan
  • Tomoko  Matsukawa
    Tomoko Matsukawa GlaxoSmithKline K.K., Japan
  • Ken  Nakajima
    Ken Nakajima Associate Manager, Evaluation Management, Pharmacovigilance Dept. Otsuka Pharmaceutical Co., Ltd., Japan
  • Yuji  Ohne
    Yuji Ohne Director, Pharmacovigilance SymBio Pharmaceuticals Limited, Japan
  • Junko  Onaka
    Junko Onaka Group Manager, Labeling Group, Regulatory Compliance Dept, RA Div. Janssen Pharmaceutical K.K., Japan
  • Junko  Sato, DrSc, PhD
    Junko Sato, DrSc, PhD International Coordination Officer Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Shoji  Takamatsu, PhD
    Shoji Takamatsu, PhD Office Director, Office of Safety II Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Katsumi  Tanaka
    Katsumi Tanaka Showa University Hospital, Japan
Load More